Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

The heterogeneous transition state of resistance to RET kinase inhibitors converges on ERK1/2-driven Aurora A/B kinases

Drug Resistance Updates(2023)10.1016/j.drup.2023.100958Source: DataRank Database

The heterogeneous transition state of resistance to RET kinase inhibitors converges on ERK1/2-driven Aurora A/B kinases is a research paper published in Drug Resistance Updates (2023). On theSindex it has a DataRank of 0. It has been cited 12 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access12 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)OA: greenTopics (25)IDs (PubMed)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Xuan Liu ORCID,Ujjwol Khatri ORCID,Jie Wu ORCID,Xueqing Hu ORCID

Live enrichment

PubMed:36990046

NIH

Grant: P20GM103639

NCI

Grant: R01CA242845

NCI

Grant: P30CA016672

NCI

Grant: R01CA273168

Oklahoma Center for the Advancement of Science and Technology

Grant: HR19-026

NCI NIH HHS

Grant: P30 CA225520

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC10149623/pdf/nihms-1887626.pdf

publisherhttps://api.elsevier.com/content/article/PII:S1368764623000419?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1368764623000419?httpAccept=text/plain

Fields of Study

HumansMAP Kinase Signaling SystemAurora Kinase AAurora Kinase BNeoplasm, ResidualProto-Oncogene Proteins c-retAntineoplastic AgentsProtein Kinase InhibitorsLung Neoplasms

MeSH Terms

HumansMAP Kinase Signaling SystemAurora Kinase AAurora Kinase BNeoplasm, ResidualProto-Oncogene Proteins c-retAntineoplastic AgentsProtein Kinase InhibitorsLung Neoplasms

Keywords

AuroraERK1/2Protein kinasesRETResidual tumorsTargeted therapyTherapy resistance